HB 264 is AN ACT establishing a commission to study allowing pharmacists to prescribe oral contraceptives and other drugs. (This is as amended from its original version.)
History: The American Academy of Obstetricians and Gynecologists recommends that oral contraceptives be available OTC. In studies based in countries with OTC oral contraceptives (India, Portugal, all of South America, etc.), women were found to be able to make appropriate decisions about choice of oral contraceptive and use a screening tool effectively, although generally more conservative than clinicians. Receiving a 12 month supply of oral contraceptive increased use and decreased unintended pregnancy rates by 30%. ACOG’s only issue is that focus on expanding access by allowing Pharmacists to prescribe oral contraceptives is simply substituting one barrier with another. Eight states have Pharmacist prescription of oral contraceptives, including VT, WA, OR, HI, IL, NY, MN, MD(2018), with CA in process.
NHNA’s Commission on Government Affairs is in favor of the passage of HB 264, as presented at the Legislative Town Hall Forum on January 26.
An initial hearing on this bill was held on January 18. A subcommittee work session was held on January 24. This bill was amended to add an RN to the commission, as appointed by NHNA.
On 2/22/17 this bill PASSED in the House and moved to Senate Health & Human Services Committee on 2/22/17.
Sara Kellogg Meade spoke in favor of this bill on behalf of NHNA at the hearing before Senate Committee on Health & Human Services on 3/28/17. On 4/6/17 this bill PASSED in the Senate. NHNA has a seat on the Commission that will be created by this bill.
The Governor signed this bill on 4/25/17 (Chapter No: 2017-23).